Copyright (c) 2009 Yahoo! Inc. All rights reserved. http://news.yahoo.com/i/1285 health Health - Cancer en-us Fri, 03 Jul 2009 23:03:12 GMT 5 142 18 http://news.yahoo.com/i/1285 http://l.yimg.com/a/i/us/nws/th/main_142b.gif http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/hsn/20090703/hl_hsn/cellpathwaymaybekeytolungcancersspread hsn/20090703/cellpathwaymaybekeytolungcancersspread HealthDay health Fri, 03 Jul 2009 23:03:12 GMT HealthDay - FRIDAY, July 3 (HealthDay News) -- U.S. researchers say they've found a major cellular flaw that may drive the rapid spread of relapsed lung cancer. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/nm/20090703/hl_nm/us_prostate_cancer nm/20090703/us_prostate_cancer Reuters health Fri, 03 Jul 2009 14:45:43 GMT Reuters - PSA blood tests are often used to screen men for prostate cancer, but there is still no good evidence that they cut death rates from the disease, a new review finds. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/hsn/20090703/hl_hsn/anothergeneticlinktotesticularcancerisfound hsn/20090703/anothergeneticlinktotesticularcancerisfound HealthDay health Fri, 03 Jul 2009 03:49:05 GMT HealthDay - THURSDAY, July 2 (HealthDay News) -- A second gene linked to inherited testicular germ-cell cancer has been identified by scientists at the U.S. National Institutes of Health. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/hsn/20090703/hl_hsn/newdrugcouldworkagainstleukemia hsn/20090703/newdrugcouldworkagainstleukemia HealthDay health Fri, 03 Jul 2009 03:49:01 GMT HealthDay - THURSDAY, July 2 (HealthDay News) -- A new targeted therapy shows promise in treating acute myeloid leukemia, a highly treatment-resistant blood cancer, according to a new study. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/hsn/20090703/hl_hsn/cancerendangerssomewildlifespecies hsn/20090703/cancerendangerssomewildlifespecies HealthDay health Fri, 03 Jul 2009 03:48:54 GMT HealthDay - THURSDAY, July 2 (HealthDay News) -- Cancer is a major threat to certain species of wildlife, which need to be protected through health monitoring, researchers say. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/nm/20090702/hl_nm/us_birth_weight_leukemia nm/20090702/us_birth_weight_leukemia Reuters health Thu, 02 Jul 2009 22:43:12 GMT Reuters - There may be an association between high birth weight and an increased risk of overall leukemia and acute lymphoblastic leukemia (ALL). The increased risk of acute myeloid leukemia (AML) appears to be associated with the high and low extremes of birth weight. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/hsn/20090702/hl_hsn/fdatellspatientstostickwithdiabetesdruglinkedtocancer hsn/20090702/fdatellspatientstostickwithdiabetesdruglinkedtocancer HealthDay health Thu, 02 Jul 2009 03:49:10 GMT HealthDay - WEDNESDAY, July 1 (HealthDay News) -- Despite recent studies suggesting that the injected diabetes drug Lantus (insulin glargine) might boost cancer risk, the U.S. Food and Drug Administration on Wednesday urged patients who are on the medication to continue using it. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/ap/20090702/ap_on_he_me/us_med_fawcett_anal_cancer ap/20090702/us_med_fawcett_anal_cancer AP health Thu, 02 Jul 2009 00:07:38 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/ap/20090702/ap_on_he_me/us_med_fawcett_anal_cancer"><img src="http://d.yimg.com/a/p/afp/20090701/capt.photo_1246416281036-1-0.jpg?x=130&y=83&q=85&sig=hdmaHugqb7xzFaEHdIoL2Q--" align="left" height="83" width="130" alt="Hundreds of mourners paid tribute to Farrah Fawcett as the "Charlie's Angels" star was laid to rest in a private ceremony in Los Angeles. The 62-year-old actress and pin-up girl died last Thursday after a three-year battle with anal cancer, news that was quickly overshadowed by the death of King of Pop Michael Jackson later that day.(AFP/Getty Images/Jason Merritt)" border="0" /></a>AP - In a perverse twist of medical fate, Farrah Fawcett has become the poster girl for anal cancer, a rare disease often linked to a sexually transmitted virus.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/ap/20090702/ap_on_he_me/us_med_fawcett_anal_cancer"><img src="http://d.yimg.com/a/p/afp/20090701/capt.photo_1246416281036-1-0.jpg?x=130&y=83&q=85&sig=hdmaHugqb7xzFaEHdIoL2Q--" align="left" height="83" width="130" alt="photo" title="Hundreds of mourners paid tribute to Farrah Fawcett as the "Charlie's Angels" star was laid to rest in a private ceremony in Los Angeles. The 62-year-old actress and pin-up girl died last Thursday after a three-year battle with anal cancer, news that was quickly overshadowed by the death of King of Pop Michael Jackson later that day.(AFP/Getty Images/Jason Merritt)" border="0"/></a></p><br clear="all"/> (AP) http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/nm/20090701/hl_nm/us_cancer_lung_scans nm/20090701/us_cancer_lung_scans Reuters health Wed, 01 Jul 2009 21:53:51 GMT Reuters - Devices that simultaneously take a PET scan and a CT scan can eliminate unnecessary surgery for lung cancer, although they do little to save lives, researchers in Denmark reported on Wednesday. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/nm/20090701/hl_nm/us_fda_lantus nm/20090701/us_fda_lantus Reuters health Wed, 01 Jul 2009 20:18:01 GMT Reuters - The U.S. Food and Drug Administration on Wednesday cast doubt on recent studies that suggested possible cancer risk with Sanofi-Aventis' widely used Lantus diabetes drug, boosting investor confidence in the blockbuster product. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/mcclatchy/20090701/sc_mcclatchy/3263949 mcclatchy/20090701/3263949 McClatchy Newspapers health Wed, 01 Jul 2009 19:48:00 GMT McClatchy Newspapers - WASHINGTON — For a human cell, this is a scary world. Each of the 60 trillion or so cells in the average person's body is damaged tens of thousands, perhaps a million, times a day, scientists say. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/ap/20090701/ap_on_sc/us_med_genetics_prize ap/20090701/us_med_genetics_prize AP health Wed, 01 Jul 2009 14:17:30 GMT AP - An 84-year-old University of Chicago researcher has won a half-million-dollar genetics prize for her pioneering work in showing that cancer is a genetic disease. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/hsn/20090701/hl_hsn/metabolicsyndromemaymakebreastcancermorelikely hsn/20090701/metabolicsyndromemaymakebreastcancermorelikely HealthDay health Wed, 01 Jul 2009 03:48:39 GMT HealthDay - TUESDAY, June 30 (HealthDay News) -- Women with high blood pressure, elevated glucose and other components of metabolic syndrome might be at increased risk for postmenopausal breast cancer, a new study suggests. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/hsn/20090701/hl_hsn/onlinegenetictestingappearstohavebenefits hsn/20090701/onlinegenetictestingappearstohavebenefits HealthDay health Wed, 01 Jul 2009 03:48:38 GMT HealthDay - TUESDAY, June 30 (HealthDay News) -- Online genetic testing for lung cancer appears to offer some benefits to patients, according to U.S. researchers who evaluated the use of an online test among 44 smokers. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/nm/20090630/hl_nm/us_pfizer nm/20090630/us_pfizer Reuters health Tue, 30 Jun 2009 21:55:21 GMT Reuters - Pfizer Inc said a late stage trial testing its cancer drug Sutent in advanced colon cancer was discontinued after it was deemed to be no more effective than standard chemotherapy. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/nm/20090630/hl_nm/us_breast_cancer_treatments_impact_work_stat nm/20090630/us_breast_cancer_treatments_impact_work_stat Reuters health Tue, 30 Jun 2009 20:28:56 GMT Reuters - Among working women with newly diagnosed breast cancer, those treated with chemotherapy appear more likely to experience a major change in work status, study findings suggest. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/hsn/20090630/hl_hsn/newdrugpromisingagainstrheumatoidarthritis hsn/20090630/newdrugpromisingagainstrheumatoidarthritis HealthDay health Tue, 30 Jun 2009 03:49:34 GMT HealthDay - MONDAY, June 29 (HealthDay News) -- The immunosuppressive drug golimumab shows promise in treating rheumatoid arthritis patients who don't respond to other drugs, according to a new study. Golimumab is from the family of drugs called tumor necrosis factor-a (TNF-a) inhibitors. http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/afp/20090629/hl_afp/healthuscancer afp/20090629/healthuscancer AFP health Mon, 29 Jun 2009 21:55:25 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/afp/20090629/hl_afp/healthuscancer"><img src="http://d.yimg.com/a/p/afp/20090630/capt.photo_1246312447854-1-0.jpg?x=130&y=86&q=85&sig=6AzGA60qXvf6YFVltOvjQw--" align="left" height="86" width="130" alt="Doctors and nurses discuss cases at a hospital in the US. Two National Institutes of Health (NIH) practitioners have questioned the wisdom and utility of treating terminally ill cancer patients with expensive treatments that only extend their lives by weeks.(AFP/File/Robyn Beck)" border="0" /></a>AFP - Two National Institutes of Health (NIH) practitioners have questioned the wisdom and utility of treating terminally ill cancer patients with expensive treatments that only extend their lives by weeks.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/afp/20090629/hl_afp/healthuscancer"><img src="http://d.yimg.com/a/p/afp/20090630/capt.photo_1246312447854-1-0.jpg?x=130&y=86&q=85&sig=6AzGA60qXvf6YFVltOvjQw--" align="left" height="86" width="130" alt="photo" title="Doctors and nurses discuss cases at a hospital in the US. Two National Institutes of Health (NIH) practitioners have questioned the wisdom and utility of treating terminally ill cancer patients with expensive treatments that only extend their lives by weeks.(AFP/File/Robyn Beck)" border="0"/></a></p><br clear="all"/> (AFP) http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/afp/20090629/hl_afp/healthaustraliacancerresearch afp/20090629/healthaustraliacancerresearch AFP health Mon, 29 Jun 2009 16:10:23 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/afp/20090629/hl_afp/healthaustraliacancerresearch"><img src="http://d.yimg.com/a/p/afp/20090630/capt.photo_1246285321847-1-0.jpg?x=130&y=78&q=85&sig=ncco15E6IGqkb63p2iWRbg--" align="left" height="78" width="130" alt="Two women look at prostate cancer cells under a microscope. Australian researchers are set to begin human trials of a tiny nano-cell that acts as a "Trojan horse" against cancer cells, a breakthrough they say may curb the need for debilitating chemotherapy.(AFP/File/William West)" border="0" /></a>AFP - Australian researchers are set to begin human trials of a tiny nano-cell that acts as a "Trojan horse" against cancer cells, a breakthrough they say may curb the need for debilitating chemotherapy.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/afp/20090629/hl_afp/healthaustraliacancerresearch"><img src="http://d.yimg.com/a/p/afp/20090630/capt.photo_1246285321847-1-0.jpg?x=130&y=78&q=85&sig=ncco15E6IGqkb63p2iWRbg--" align="left" height="78" width="130" alt="photo" title="Two women look at prostate cancer cells under a microscope. Australian researchers are set to begin human trials of a tiny nano-cell that acts as a "Trojan horse" against cancer cells, a breakthrough they say may curb the need for debilitating chemotherapy.(AFP/File/William West)" border="0"/></a></p><br clear="all"/> (AFP) http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/nm/20090629/hl_nm/us_cancer_australia nm/20090629/us_cancer_australia Reuters health Mon, 29 Jun 2009 09:57:53 GMT Reuters - Australian scientists have developed a "trojan horse" therapy to combat cancer, using a bacterially-derived nano cell to penetrate and disarm the cancer cell before a second nano cell kills it with chemotherapy drugs.